Clinical Trial Update: LGG Supplementation in Patients With AUD and ALD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating LGG probiotic supplementation in adults with alcohol use disorder and alcohol-associated liver disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcohol-related Liver Disease

Drugs mentioned

• LGG probiotic supplement (Lactobacillus rhamnosus GG) (Lactobacillus rhamnosus GG)

Snippet

Sponsor: University of Louisville | Conditions: Alcohol Use Disorder, Alcohol-associated Liver Disease | Phase 2 | Status: RECRUITING